Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros

Banco de datos
Tipo del documento
Intervalo de año de publicación
1.
Ann Surg ; 259(2): 229-35, 2014 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-23989052

RESUMEN

OBJECTIVE: This article reviews the current understanding of transient receptor potential ion channels (TRP channels) in health and disease. BACKGROUND: Transient receptor potential ion channels are a group of 27 channels that are expressed in all tissues. These channels play important roles in surgically important problems, such as chronic pain, susceptibility to infection, hypothermia, and some cancers. METHODS: A literature search was performed. This review focuses on the role of TRP channels in a few surgically important disease processes, such as pain, inflammation, airway diseases, and malignant melanomas. In addition, we discuss some of the structural properties that are important for the activation of TRP channels. RESULTS: TRPA1 and TRPV1 are expressed on pain fibers and play an important role in the development of chronic pain, such as chemotherapy-related neuropathic pain. Deletion of TRPA1 and TRPV1 suppresses the development of chronic pain, and blockers of TRPA1 and TRPV1 show promise as a new class of painkillers. Furthermore, several TRP channels are expressed on immune cells. Macrophages express at least 3 different TRP channels, and the properly balanced activation of all these channels together allows normal macrophage function. Deletion of any of these channels results in impaired macrophage function and increased susceptibility to infection. Because several of these TRP channels on macrophages are temperature sensitive, they may comprise the link for hypothermia-related infectious complications in trauma, and to a lesser degree, in elective surgical patients. CONCLUSIONS: Transient receptor potential ion channels are involved in several surgically important disease processes. Activation or blockade of these channels offers new therapeutic opportunities. Pharmacologic activation or blockade of TRP channels may offer new treatment options in surgical patients for the management of pain and infections.


Asunto(s)
Dolor Crónico/metabolismo , Inflamación/metabolismo , Canales de Potencial de Receptor Transitorio/metabolismo , Analgésicos/uso terapéutico , Antiinflamatorios/uso terapéutico , Biomarcadores/metabolismo , Canales de Calcio/metabolismo , Capsaicina/uso terapéutico , Clorhidrato de Duloxetina , Humanos , Inflamación/tratamiento farmacológico , Macrófagos/metabolismo , Melanoma/metabolismo , Monocitos/metabolismo , Proteínas del Tejido Nervioso/antagonistas & inhibidores , Proteínas del Tejido Nervioso/metabolismo , Dolor Postoperatorio/tratamiento farmacológico , Dolor Postoperatorio/metabolismo , Enfermedades Respiratorias/metabolismo , Infección de la Herida Quirúrgica/metabolismo , Infección de la Herida Quirúrgica/prevención & control , Canal Catiónico TRPA1 , Canales Catiónicos TRPV/antagonistas & inhibidores , Canales Catiónicos TRPV/metabolismo , Tiofenos/uso terapéutico , Canales de Potencial de Receptor Transitorio/antagonistas & inhibidores , Canales de Potencial de Receptor Transitorio/inmunología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA